Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D
Institut National de la Santé et de la Recherche Médicale U370, Necker/Pasteur Institute, 75730 Paris Cedex 15, France.
Cancer Res. 2001 Nov 1;61(21):7803-10.
The hepatitis B virus (HBV) X protein (HBx) is a transcriptional transactivator that has been implicated in the development of HBV-related hepatocellular carcinoma. Mutations in the HBx open reading frame have been reported, but their general impact on the biological function of HBx remains unknown. To address this issue, we comparatively analyzed the structures and biological functions of HBx sequences isolated from sera and from tumor and nontumor tissues of patients with a HBV-related hepatocellular carcinoma. In addition to the HBx sequences derived from free HBV genomes, HBx from HBV integrants was also obtained from the tumor tissues by use of a HBx-Alu PCR-based approach. Sequence analysis showed that the HBx sequences derived from tumor tissues (6 of 7), particularly those isolated from HBV integrants (4 of 4), contained a deletion in the distal COOH-terminal region. Interestingly, most of the COOH-terminally truncated HBx sequences obtained from tumor tissues, in contrast to the full-length HBx isolated from the sera and nontumor tissues, lost their transcriptional activity and their inhibitory effects on cell proliferation and transformation. Importantly, although full-length HBx suppressed the focus formation induced by the cooperation of ras and myc oncogenes in primary rat embryo fibroblasts, COOH-terminally truncated HBx enhanced the transforming ability of ras and myc. Finally, by analyzing the artificial mutants, we were able to more precisely map the functional domains located at the COOH-terminal of HBx. Taken together, our results suggest a key role for the HBx COOH-terminal end in controlling cell proliferation, viability, and transformation. This study further supports the hypothesis that natural HBx mutants might be selected in tumor tissues and play a role in hepatocarcinogenesis by modifying the biological functions of HBx.
乙型肝炎病毒(HBV)X蛋白(HBx)是一种转录反式激活因子,与HBV相关肝细胞癌的发生发展有关。已有报道称HBx开放阅读框存在突变,但其对HBx生物学功能的总体影响尚不清楚。为解决这一问题,我们比较分析了从HBV相关肝细胞癌患者血清、肿瘤组织和非肿瘤组织中分离得到的HBx序列的结构和生物学功能。除了源自游离HBV基因组的HBx序列外,还通过基于HBx-Alu PCR的方法从肿瘤组织中获得了来自HBV整合体的HBx。序列分析表明,源自肿瘤组织的HBx序列(7个中有6个),特别是从HBV整合体中分离得到的序列(4个均是),在COOH末端远端区域存在缺失。有趣的是,与从血清和非肿瘤组织中分离得到的全长HBx相比,从肿瘤组织中获得的大多数COOH末端截短的HBx序列失去了转录活性以及对细胞增殖和转化的抑制作用。重要的是,虽然全长HBx抑制了原代大鼠胚胎成纤维细胞中ras和myc癌基因协同诱导的集落形成,但COOH末端截短的HBx增强了ras和myc的转化能力。最后,通过分析人工突变体,我们能够更精确地定位位于HBx COOH末端的功能域。综上所述,我们的结果表明HBx的COOH末端在控制细胞增殖、活力和转化中起关键作用。本研究进一步支持了以下假设:天然HBx突变体可能在肿瘤组织中被选择,并通过改变HBx的生物学功能在肝癌发生中发挥作用。